These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. The 'number needed to treat' with levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs). van Rijckevorsel K; Boon PA Seizure; 2002 Apr; 11 Suppl A():235-6. PubMed ID: 12185762 [No Abstract] [Full Text] [Related]
48. Felbamate, gabapentin and topiramate as adjuvant antiepileptic drugs in experimental models of epilepsy. Czuczwar SJ; Przesmycki K Pol J Pharmacol; 2001; 53(1):65-8. PubMed ID: 11785915 [TBL] [Abstract][Full Text] [Related]
49. New antiepileptic drugs and preparations. Yoon Y; Jagoda A Emerg Med Clin North Am; 2000 Nov; 18(4):755-65. PubMed ID: 11130937 [TBL] [Abstract][Full Text] [Related]
50. New anticonvulsants for use in pediatric patients (part I). Kopec K J Pediatr Health Care; 2001; 15(2):81-6; quiz 87-8. PubMed ID: 11246198 [No Abstract] [Full Text] [Related]
51. New antiepileptic drugs: case studies. Bannister SM; Morton LD; Pellock JM Semin Pediatr Neurol; 1997 Mar; 4(1):64-7. PubMed ID: 9097368 [No Abstract] [Full Text] [Related]
52. New pharmacotherapies for pediatric seizures. Pellock JM Pediatr Ann; 2004 Jun; 33(6):385-91. PubMed ID: 19449513 [No Abstract] [Full Text] [Related]
53. Utilization of new antiepileptic drugs in children. Pellock JM Epilepsia; 1996; 37 Suppl 1():S66-73. PubMed ID: 8647054 [TBL] [Abstract][Full Text] [Related]
54. Advances in the pharmacotherapy of epilepsy. Ramsay RE Epilepsia; 1993; 34 Suppl 5():S9-16. PubMed ID: 8339715 [TBL] [Abstract][Full Text] [Related]
55. Pharmacologic and dietary therapies in epilepsy: conventional treatments and recent advances. Chapman DP; Giles WH South Med J; 1997 May; 90(5):471-80. PubMed ID: 9160061 [TBL] [Abstract][Full Text] [Related]
56. New antiepileptic drugs. II. Clinical use. Lee BI J Korean Med Sci; 1996 Aug; 11(4):289-304. PubMed ID: 8878797 [No Abstract] [Full Text] [Related]
57. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ; Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822 [TBL] [Abstract][Full Text] [Related]
58. Bipolar disorders and the effectiveness of novel anticonvulsants. Calabrese JR; Shelton MD; Rapport DJ; Kimmel SE J Clin Psychiatry; 2002; 63 Suppl 3():5-9. PubMed ID: 11908919 [TBL] [Abstract][Full Text] [Related]
59. Antiepileptic drugs in migraine prophylaxis: state of the art. Capuano A; Vollono C; Mei D; Pierguidi L; Ferraro D; Di Trapani G Clin Ter; 2004; 155(2-3):79-87. PubMed ID: 15244112 [TBL] [Abstract][Full Text] [Related]